GR78629B - - Google Patents

Info

Publication number
GR78629B
GR78629B GR71903A GR830171903A GR78629B GR 78629 B GR78629 B GR 78629B GR 71903 A GR71903 A GR 71903A GR 830171903 A GR830171903 A GR 830171903A GR 78629 B GR78629 B GR 78629B
Authority
GR
Greece
Prior art keywords
alkyl
nitroxy
halogen
hydrogen
pharmaceutically acceptable
Prior art date
Application number
GR71903A
Other languages
Greek (el)
English (en)
Inventor
Ikuo Ueda
Daizo Morino
Koichi Takimoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of GR78629B publication Critical patent/GR78629B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
GR71903A 1982-07-26 1983-07-11 GR78629B (US06291489-20010918-C00077.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8221592 1982-07-26

Publications (1)

Publication Number Publication Date
GR78629B true GR78629B (US06291489-20010918-C00077.png) 1984-09-27

Family

ID=10531922

Family Applications (1)

Application Number Title Priority Date Filing Date
GR71903A GR78629B (US06291489-20010918-C00077.png) 1982-07-26 1983-07-11

Country Status (17)

Country Link
US (2) US4540701A (US06291489-20010918-C00077.png)
EP (1) EP0100081B1 (US06291489-20010918-C00077.png)
JP (1) JPS5951263A (US06291489-20010918-C00077.png)
KR (1) KR900005470B1 (US06291489-20010918-C00077.png)
AT (1) ATE40948T1 (US06291489-20010918-C00077.png)
AU (1) AU565791B2 (US06291489-20010918-C00077.png)
CA (1) CA1216850A (US06291489-20010918-C00077.png)
DE (1) DE3379255D1 (US06291489-20010918-C00077.png)
DK (1) DK311683A (US06291489-20010918-C00077.png)
ES (1) ES8502088A1 (US06291489-20010918-C00077.png)
FI (1) FI832490L (US06291489-20010918-C00077.png)
GR (1) GR78629B (US06291489-20010918-C00077.png)
HU (1) HU190497B (US06291489-20010918-C00077.png)
NO (1) NO832700L (US06291489-20010918-C00077.png)
PH (1) PH18083A (US06291489-20010918-C00077.png)
SU (1) SU1189337A3 (US06291489-20010918-C00077.png)
ZA (1) ZA835048B (US06291489-20010918-C00077.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd 2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPS6215A (ja) * 1985-02-26 1987-01-06 Fujisawa Pharmaceut Co Ltd 2−ニトロオキシメチル−6−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤
ZA885069B (en) * 1987-07-24 1989-03-29 Fujisawa Pharmaceutical Co Sustained-release percutaneous preparations
JPH02167279A (ja) * 1988-09-30 1990-06-27 Taisho Pharmaceut Co Ltd アポビンカミン酸誘導体
US5047543A (en) * 1988-11-24 1991-09-10 Taisho Pharmaceutical Co., Ltd. 1,4-dihydropyridine derivatives
CN106318877A (zh) * 2016-08-29 2017-01-11 刘翔 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275642A (en) * 1962-04-26 1966-09-27 Bard Pharmaceutical Inc 3-pyridine carbinol nitrate and its preparation
US3689494A (en) * 1971-03-31 1972-09-05 William R J Simpson N-pyridinealkyl-alkanolamine nitrates

Also Published As

Publication number Publication date
KR840005426A (ko) 1984-11-12
ZA835048B (en) 1984-03-28
HU190497B (en) 1986-09-29
FI832490L (fi) 1984-01-27
KR900005470B1 (ko) 1990-07-30
DE3379255D1 (en) 1989-04-06
EP0100081B1 (en) 1989-03-01
DK311683A (da) 1984-01-27
ATE40948T1 (de) 1989-03-15
SU1189337A3 (ru) 1985-10-30
NO832700L (no) 1984-02-06
ES524375A0 (es) 1984-12-16
CA1216850A (en) 1987-01-20
JPS5951263A (ja) 1984-03-24
US4540701A (en) 1985-09-10
JPS6350343B2 (US06291489-20010918-C00077.png) 1988-10-07
EP0100081A3 (en) 1985-05-02
AU1663583A (en) 1984-02-02
EP0100081A2 (en) 1984-02-08
FI832490A0 (fi) 1983-07-07
PH18083A (en) 1985-03-18
AU565791B2 (en) 1987-10-01
US4613608A (en) 1986-09-23
ES8502088A1 (es) 1984-12-16
DK311683D0 (da) 1983-07-05

Similar Documents

Publication Publication Date Title
CA1260471C (US06291489-20010918-C00077.png)
DE3279103D1 (en) New cephem compounds, processes for preparation thereof and pharmaceutical composition containing them
ES8706664A1 (es) Procedimiento para preparar compuestos carbostirilicos
ES8505690A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
GB8530602D0 (en) Heterocyclic compounds
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
GR78629B (US06291489-20010918-C00077.png)
ES2001852A6 (es) Procedimiento para preparar un derivado de acido quinolocarboxilico
DE3362876D1 (en) Dibenzocycloheptenylidene compounds for use in modulating the immune response
GR81759B (US06291489-20010918-C00077.png)
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
ES8502094A1 (es) Un procedimiento para la preparacion de derivados de tetrahidroisoquinolina.
ES8504820A1 (es) Un procedimiento para preparar compuestos de cefem que tienen grupos tiadiazol c isotiazol.
DE3261643D1 (en) New peptide, process for preparation thereof and use thereof
ZW2885A1 (en) Quinate salts of the antimalarial compound meeloquine